Gregory A. Rippon, MD, MS
Advertisement
Chief medical partner of neurology, ophthalmology, and internal medicine at Genentech
Articles by Gregory A. Rippon, MD, MS
The chief medical partner of neurology, ophthalmology, and internal medicine at Genentech shared his perspective on the steps the field has taken to improve clinical trials and therapies for neurodegenerative diseases such as Alzheimer disease. [WATCH TIME: 3 minutes]
Advertisement
Latest Updated Articles
Applying two decades of Alzheimer’s research and doing what’s right for patientsPublished: September 22nd 2022 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Preliminary Phase 2 Data Support Therapeutic Development of Synaptic Regenerative Drug SPG302 in ALS
2
Dental Caries and Periodontal Disease Increase Ischemic Stroke Risk, Study Shows
3
Therapeutic Promise and Mechanism of DYNE-101 to Treat Myotonic Dystrophy: Doug Kerr, MD, PhD
4
Ensuring a Comprehensive Diagnosis of CIDP and the Role of EMG
5
